Literature DB >> 21921059

In situ hybridisation for the detection of Leishmania species in paraffin wax-embedded canine tissues using a digoxigenin-labelled oligonucleotide probe.

N Dinhopl1, M M Mostegl, B Richter, N Nedorost, A Maderner, K Fragner, H Weissenböck.   

Abstract

The diagnosis of canine leishmaniosis (CanL) is currently predominantly achieved by cytological or histological identification of amastigotes in biopsy samples, demonstration of specific anti-Leishmania antibodies and PCR-based approaches. All these methods have the advantage of being sensitive and more or less specific; nevertheless, most of them also have disadvantages. A chromogenic in situ hybridisation (ISH) procedure with a digoxigenin-labelled probe, targeting a fragment of the 5.8S rRNA was developed for the detection of all species of Leishmania parasites in routinely paraffin wax-embedded canine tissues. This method was validated in comparison with traditional techniques (histology, PCR), on various tissues from three dogs with histological changes consistent with a florid leishmaniosis. Amastigote forms of Leishmania gave clear signals and were easily identified using ISH. Various tissues from 10 additional dogs with clinical suspicion or/and a positive serological test but without histological presence of amastigotes did not show any ISH signals. Potential cross-reactivity of the probe was ruled out by negative outcome of the ISH against selected protozoa (including the related Trypanosoma cruzi) and fungi. Thus, ISH proved to be a powerful tool for unambiguous detection of Leishmania parasites in paraffin wax-embedded tissues.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21921059      PMCID: PMC3217050          DOI: 10.1136/vr.d5462

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  27 in total

1.  Effect of buffered formalin on amplification of DNA from paraffin wax embedded small biopsies using real-time PCR.

Authors:  V Zsikla; M Baumann; G Cathomas
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

2.  Leishmania major-like antigen for specific and sensitive serodiagnosis of human and canine visceral leishmaniasis.

Authors:  Rosângela Barbosa-De-Deus; Marcos Luíz Dos Mares-Guia; Adriane Zacarias Nunes; Kátia Morais Costa; Roberto Gonçalves Junqueira; Wilson Mayrink; Odair Genaro; Carlos Alberto Pereira Tavares
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

3.  Canine visceral leishmaniosis: a remarkable histopathological picture of one case reported from Brazil.

Authors:  W L Tafuri; M R de Oliveira; M N Melo; W L Tafuri
Journal:  Vet Parasitol       Date:  2001-04-02       Impact factor: 2.738

4.  Evaluation of a newly developed direct agglutination test (DAT) for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis: comparison with IFAT and ELISA.

Authors:  A E Harith; A H Kolk; P A Kager; J Leeuwenburg; F J Faber; R Muigai; S Kiugu; J J Laarman
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

Review 5.  Canine leishmaniasis: epidemiological risk and the experimental model.

Authors:  Javier Moreno; Jorge Alvar
Journal:  Trends Parasitol       Date:  2002-09

Review 6.  Atypical forms of canine leishmaniosis.

Authors:  A Blavier; S Keroack; P Denerolle; I Goy-Thollot; L Chabanne; J L Cadoré; G Bourdoiseau
Journal:  Vet J       Date:  2001-09       Impact factor: 2.688

Review 7.  Molecular biological applications in the diagnosis and control of leishmaniasis and parasite identification.

Authors:  Henk D F H Schallig; Linda Oskam
Journal:  Trop Med Int Health       Date:  2002-08       Impact factor: 2.622

8.  Serodiagnosis of Sudanese visceral and mucosal leishmaniasis: comparison of ELISA--immunofluorescence and indirect haemagglutination.

Authors:  E R el Amin; E P Wright; A M Abdel Rahman; A Kolk; J J Laarman; K W Pondman
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

9.  An alternative immunohistochemical method for detecting Leishmania amastigotes in paraffin-embedded canine tissues.

Authors:  Wagner Luiz Tafuri; Renato de Lima Santos; Rosa Maria Esteves Arantes; Ricardo Gonçalves; Maria Norma de Melo; Marilene Suzan Marques Michalick; Washington Luiz Tafuri
Journal:  J Immunol Methods       Date:  2004-09       Impact factor: 2.303

10.  [Canine visceral leishmaniasis: evaluation of the serologic method used in epidemiologic studies].

Authors:  C A da Costa; O Genaro; M de Lana; P A Magalhães; M Dias; M S Michalick; M N Melo; R T da Costa; N M Magalhães-Rocha; W Mayrink
Journal:  Rev Soc Bras Med Trop       Date:  1991 Jan-Mar       Impact factor: 1.581

View more
  4 in total

1.  Diagnosing Cutaneous leishmaniasis using Fluorescence in Situ Hybridization: the Sri Lankan Perspective.

Authors:  Thilini Dilhara Jayasena Kaluarachchi; Manjula Manoji Weerasekera; Andrew J McBain; Shalindra Ranasinghe; Renu Wickremasinghe; Surangi Yasawardene; Nisal Jayanetti; Rajitha Wickremasinghe
Journal:  Pathog Glob Health       Date:  2019-08-20       Impact factor: 2.894

2.  Sensitivity and specificity of in situ hybridization for diagnosis of cutaneous infection by Leishmania infantum in dogs.

Authors:  Rodrigo C Menezes; Fabiano B Figueiredo; Annabel G Wise; Maria F Madeira; Raquel V C Oliveira; Tânia M P Schubach; Matti Kiupel; Ingeborg M Langohr
Journal:  J Clin Microbiol       Date:  2012-11-07       Impact factor: 5.948

3.  Comparative study of in situ hybridization, immunohistochemistry and parasitological culture for the diagnosis of canine leishmaniosis.

Authors:  Marina C Furtado; Rodrigo C Menezes; Matti Kiupel; Maria F Madeira; Raquel V C Oliveira; Ingeborg M Langohr; Fabiano B Figueiredo
Journal:  Parasit Vectors       Date:  2015-12-02       Impact factor: 3.876

4.  Small RNAs derived from tRNAs and rRNAs are highly enriched in exosomes from both old and new world Leishmania providing evidence for conserved exosomal RNA Packaging.

Authors:  Ulrike Lambertz; Mariana E Oviedo Ovando; Elton J R Vasconcelos; Peter J Unrau; Peter J Myler; Neil E Reiner
Journal:  BMC Genomics       Date:  2015-03-05       Impact factor: 3.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.